Story thread · 2 reports / 2 sources
Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train
endpts.com · 5h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
A California biotech with a chronic pain drug that's long been approved in Italy, but not the US, is going onto the public markets through the increasingly popular reverse merger route. Ambros ...
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.